A Study Evaluating the Safety of Stratagraft® Skin Tissue in Promoting Skin Tissue Regeneration of Complex Skin Defects Due to Thermal Burns

Status: open

17-344 -Phase 3 open-label, controlled, randomized, multicenter study evaluating the efficacy and safety of Stratagraft® skin tissue in promoting autologous skin tissue regeneration of complex skin defects due to thermal burns that contain intact dermal elements

Treatment for Thermal Burns

Contact Us Or call 251-471-7988

Description

The proposed registration study is designed as a phase III open-label, controlled, randomized, multicenter study evaluating the efficacy and safety of StrataGraft skin tissue in promoting autologous skin tissue regeneration of complex skin defects due to thermal burns. IRB Number 17-344

Sponsors

This trial is sponsored by Stratatech.

Providers Associated With This Trial

Principle Investigator

    Sub Investigators

    This link will open in a new tab or window.